Market Cap

Proteome Sciences plc Market Capitalization:

£14.8 Million

GBP as of Jan. 1, 2024

US$18.9 Million

business Proteome Sciences plc Company Profile

Proteome Sciences plc Main Stock Listing

LSE: PRM

Market Capitalization History of Proteome Sciences plc

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Diagnostics & Research
Company Market Cap (USD)
Thermo Fisher Scientific $207.62 B
Danaher $171.89 B
Siemens Healthineers AG $66.05 B
DexCom, Inc. $46.50 B
IDEXX Laboratories, Inc. $44.72 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $586.39 B
UnitedHealth Group $504.47 B
Novo Nordisk $461.52 B
Johnson & Johnson $387.50 B
Merck $296.51 B

Yearly evolution of Proteome Sciences plc market cap

Date Market Cap YoY Change
Jan. 1, 2024 £14.8 M 18.35%
Jan. 1, 2023 £12.5 M -13.98%
Jan. 1, 2022 £14.6 M 15.96%
Jan. 1, 2021 £12.6 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +269.94%

$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

Proteome Sciences plc Categories

United Kingdom languages Healthcare languages Diagnostics & Research
United Kingdom Healthcare United Kingdom Diagnostics & Research

Stocks & Indices

Proteome Sciences plc has the following listings and related stock indices.


Stock: LSE: PRM

Stock: FSX: PI2

Stock: OTC: PMSNF

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.